All Pharma News
SwanBio Appointed Executive Chair and Chief Operating Officer

SwanBio Appointed Executive Chair and Chief Operating Officer
BUSINESSWIRE
16 Oct 2023
Share Share
SwanBio Advances to Higher-Dose Cohort in First-in-Human Study of Gene Therapy

SwanBio Advances to Higher-Dose Cohort in First-in-Human Study of Gene Therapy
BUSINESSWIRE
04 Oct 2023
Share Share
SwanBio Unveils Research in Next Generation CNS Capsids at ASGCT

SwanBio Unveils Research in Next Generation CNS Capsids at ASGCT
BUSINESSWIRE
18 May 2023
Share Share
SwanBio Therapeutics Confirms Substantial Burden of Disease of (AMN)

SwanBio Therapeutics Confirms Substantial Burden of Disease of (AMN)
BUSINESSWIRE
10 May 2023
Share Share
SwanBio Therapeutics initiates Phase I/II trial of gene therapy for AMN

SwanBio Therapeutics initiates Phase I/II trial of gene therapy for AMN
CLINICALTRIALSARENA
16 Dec 2022
Share Share
SwanBio Therapeutics Initiates First-in-Human Study of AAV Gene Therapy

SwanBio Therapeutics Initiates First-in-Human Study of AAV Gene Therapy
BUSINESSWIRE
15 Dec 2022
Share Share
Purespring and SwanBio announce licensing agreement for use of FunSel screening

Purespring and SwanBio announce licensing agreement for use of FunSel screening
GLOBENEWSWIRE
18 Jul 2022
Share Share
SwanBio Presents Design of Innovative Natural History Study

SwanBio Presents Design of Innovative Natural History Study
BUSINESSWIRE
27 Jun 2022
Share Share
SwanBio leans heavily on Syncona to close $56M series B

SwanBio leans heavily on Syncona to close $56M series B
Nick Paul Taylor FIERCEBIOTECH
18 May 2022
Share Share
SwanBio Therapeutics Announces $56M Series B Financing

SwanBio Therapeutics Announces $56M Series B Financing
BUSINESSWIRE
18 May 2022
Share Share